Abstract
Introduction: Type 2 Diabetes (T2D) is a major health problem worldwide. This metabolic disease is indicated by high blood glucose levels due to insufficient insulin production by the pancreas. An inflammatory response occurs as a result of the immune response to high blood glucose levels as well as the presence of inflammatory mediators produced by adipocytes and macrophages in fat tissue. This low and chronic inflammation damages the pancreatic beta cells and leads to insufficient insulin production, which results in hyperglycemia.
Hyperglycemia in diabetes is thought to cause dysfunction of the immune response, which fails to control the spread of invading pathogens in diabetic subjects. Therefore, diabetic subjects are known to more susceptible to infections. The increased prevalence of T2D will increase the incidence of infectious diseases and related comorbidities.
Objective: This review provides an overview of the immunological aspect of T2D and the possible mechanisms that result in increased infections in diabetics.
Conclusion: A better understanding of how immune dysfunctions occur during hyperglycemia can lead to novel treatments and preventions for infectious diseases and T2D comorbidities, thus improving the outcome of infectious disease treatment in T2D patients.
Keywords: Type 2 diabetes, hyperglycemia, immune dysfunction, comorbidity, infection, treatment outcome.
Current Diabetes Reviews
Title:Type 2 Diabetes and its Impact on the Immune System
Volume: 16 Issue: 5
Author(s): Afiat Berbudi*, Nofri Rahmadika , Adi Imam Tjahjadi and Rovina Ruslami
Affiliation:
- Infectious Disease Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung,Indonesia
Keywords: Type 2 diabetes, hyperglycemia, immune dysfunction, comorbidity, infection, treatment outcome.
Abstract:
Introduction: Type 2 Diabetes (T2D) is a major health problem worldwide. This metabolic disease is indicated by high blood glucose levels due to insufficient insulin production by the pancreas. An inflammatory response occurs as a result of the immune response to high blood glucose levels as well as the presence of inflammatory mediators produced by adipocytes and macrophages in fat tissue. This low and chronic inflammation damages the pancreatic beta cells and leads to insufficient insulin production, which results in hyperglycemia.
Hyperglycemia in diabetes is thought to cause dysfunction of the immune response, which fails to control the spread of invading pathogens in diabetic subjects. Therefore, diabetic subjects are known to more susceptible to infections. The increased prevalence of T2D will increase the incidence of infectious diseases and related comorbidities.
Objective: This review provides an overview of the immunological aspect of T2D and the possible mechanisms that result in increased infections in diabetics.
Conclusion: A better understanding of how immune dysfunctions occur during hyperglycemia can lead to novel treatments and preventions for infectious diseases and T2D comorbidities, thus improving the outcome of infectious disease treatment in T2D patients.
Export Options
About this article
Cite this article as:
Berbudi Afiat *, Rahmadika Nofri , Tjahjadi Imam Adi and Ruslami Rovina , Type 2 Diabetes and its Impact on the Immune System, Current Diabetes Reviews 2020; 16 (5) . https://dx.doi.org/10.2174/1573399815666191024085838
DOI https://dx.doi.org/10.2174/1573399815666191024085838 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety Pesudomance sp. Bacteria Associated with Marine Sponge as a Promising and Sustainable Source of Bioactive Molecules
Current Pharmaceutical Biotechnology Preface [ Hot Topic: Autoimmunity (Executive Editor : Dorothea Stahl)]
Current Pharmaceutical Design Trends in Wound Repair: Cellular and Molecular Basis of Regenerative Therapy Using Electromagnetic Fields
Current Molecular Medicine The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies
Current Medicinal Chemistry Clinical Relevance of Cytokines and Inflammatory Molecules in Rheumatoid Vasculitis
Current Rheumatology Reviews Management of Musculoskeletal Complications in Patients with Hemophilia: Literature Review and Expert Recommendations
Cardiovascular & Hematological Disorders-Drug Targets Evaluation of Topical Black Seed Oil in the Treatment of Allergic Rhinitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry PC9, A New Actor in Autosomal Dominant Hypercholesterolemia
Current Genomics BRI2 Interacts with BACE1 and Regulates Its Cellular Levels by Promoting its Degradation and Reducing Its mRNA Levels
Current Alzheimer Research Investigation of Low Dose Cabazitaxel Potential as Microtubule Stabilizer in Experimental Model of Alzheimer's Disease: Restoring Neuronal Cytoskeleton
Current Alzheimer Research In Silico Modeling of P450 Substrates, Inhibitors, Activators, and Inducers
Combinatorial Chemistry & High Throughput Screening Transcriptome Analysis of Traditional Chinese Medicine ‘Kechuanning Plaster’ in the Treatment of Asthma
Combinatorial Chemistry & High Throughput Screening Natural Products: Potential for Developing Phellodendron amurense Bark Extract for Prostate Cancer Management
Mini-Reviews in Medicinal Chemistry Tocilizumab: From Rheumatic Diseases to COVID-19
Current Pharmaceutical Design Activated Protein C and Acute Kidney Injury: Selective Targeting of PAR-1
Current Drug Targets Biotransformation of Endocrine Disrupting Compounds by Selected Phase I and Phase II Enzymes – Formation of Estrogenic and Chemically Reactive Metabolites by Cytochromes P450 and Sulfotransferases
Current Medicinal Chemistry In Silico Search for Drug Targets of Natural Compounds
Current Pharmaceutical Biotechnology Physiology and Therapeutics of Vascular Endothelial Growth Factor in Tumor Immunosuppression
Current Molecular Medicine Progress in the Discovery of Treatments for C. difficile Infection: A Clinical and Medicinal Chemistry Review
Current Topics in Medicinal Chemistry